Inspire Medical Systems (INSP) Net Income towards Common Stockholders (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Net Income towards Common Stockholders data on file, last reported at -$11.3 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 477.47% year-over-year to -$11.3 million; the trailing twelve-month figure through Mar 2026 stood at $131.1 million (up 97.09% YoY), and the FY2025 full-year result was $145.4 million, up 171.77% from the prior year.
• Net Income towards Common Stockholders slipped to -$11.3 million in Q1 2026, from $136.1 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $136.1 million in Q4 2025 to a low of -$16.8 million in Q3 2022.
• A 5-year average of $7.2 million and a median of -$3.6 million in 2025 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders soared 366.89% in 2023 and tumbled 477.47% in 2026, its largest moves.
• Tracing INSP's Net Income towards Common Stockholders over 5 years: stood at $3.2 million in 2022, then soared by 366.89% to $14.8 million in 2023, then soared by 138.6% to $35.2 million in 2024, then jumped by 286.36% to $136.1 million in 2025, then sank by 108.3% to -$11.3 million in 2026.
• Business Quant data shows INSP's Net Income towards Common Stockholders at -$11.3 million in Q1 2026, $136.1 million in Q4 2025, and $9.9 million in Q3 2025.